Pathios Therapeutics

Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer. It is engaged in a fully-enabled drug discovery program to identify novel small-molecule modulators of GPR65 with expected utility in a range of autoimmune conditions as well as in certain cancers. The company is also interested in acid-sensing receptors in the immune system and their potential exploitation as targets for bringing about therapeutic benefits in a range of diseases.